GHRP-2 reduced joint inflammation and cartilage destruction in arthritic rats through anti-inflammatory mechanisms including cytokine suppression, demonstrating GH secretagogues' potential for treating inflammatory joint disease.
Key findingGHRP-2 reduced clinical arthritis scores, joint inflammation, and cartilage destruction in adjuvant-arthritic rats, suppressing pro-inflammatory cytok
What the researchers found
GHRP-2 reduced clinical arthritis scores, joint inflammation, and cartilage destruction in adjuvant-arthritic rats, suppressing pro-inflammatory cytokines (TNF-α, IL-6) — establishing GH secretagogues as anti-inflammatory agents for arthritis treatment.
Why it matters
Relevant for ghrp, inflammation, bone-joint, immune-function.
How the study worked
animal-study study on ghrp, inflammation.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2005.
The bigger picture
Advances peptide research with clinical implications.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.
American journal of physiology. Endocrinology and metabolism, 288(3), E486-92
Citation
Granado, Miriam; Priego, Teresa; Martín, Ana I; Villanúa, M Angeles; López-Calderón, Asunción. (2005). Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.. American journal of physiology. Endocrinology and metabolism, 288(3), E486-92.